SUDARSCHEM Sudarshan Chemical Industries Q1 FY27 results (Apr–Jun 2026) and concall
Sudarshan Chemical Industries Limited delivered a robust Q1 FY27, reporting strong revenue and over 60% YoY EBITDA growth, alongside significant debt reduction. The company is actively integrating its acquired business and driving value capture initiatives. However, geopolitical headwinds, including the Middle East crisis, have led to cost pressures and customer caution, impacting the RIECO segment. Management maintains FY27 guidance but will revisit it after Q2, pending further clarity on market conditions and the financial impact of an employee restructuring program.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 5.4%, net profit up 87.3% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 696 | 666 | 1,349 | 2,507 | 2,387 +243% | 2,103 +216% | 2,790 +107% | 2,642 +5% |
| EBITDA | 94 | 79 | 127 | 192 | 132 +40% | 38 −52% | 227 +79% | 259 +35% |
| Net profit | 30 | 1 | 0 | 55 | 19 −37% | -116 −11700% | 82 | 103 +87% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





